Gradient Investments LLC Eli Lilly & CO Transaction History

Gradient Investments LLC

$3.51 Billion
Q2 2024

A detailed history of Gradient Investments LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Gradient Investments LLC holds 513 shares of LLY stock, worth $453,733. This represents 0.01% of its overall portfolio holdings.

Number of Shares

513

Previous 401 27.93%

Holding current value

$453,733

Previous $311,000 49.2%

% of portfolio

0.01%

Previous 0.01%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 18, 2024	BUY	$724.87 - $909.04 $81,185 - $101,812	112 Added 27.93%	513 $464,000
Q1 2024 Apr 23, 2024	SELL	$592.2 - $792.28 $294,323 - $393,763	-497 Reduced 55.35%	401 $311,000
Q4 2023 Jan 18, 2024	BUY	$525.19 - $619.13 $118,167 - $139,304	225 Added 33.43%	898 $523,000
Q3 2023 Oct 27, 2023	SELL	$434.7 - $599.3 $3,912 - $5,393	-9 Reduced 1.32%	673 $361,000
Q2 2023 Jul 11, 2023	BUY	$350.74 - $468.98 $39,984 - $53,463	114 Added 20.07%	682 $319,000
Q1 2023 Apr 17, 2023	BUY	$310.63 - $364.82 $27,646 - $32,468	89 Added 18.58%	568 $195,000
Q4 2022 Jan 10, 2023	SELL	$321.55 - $374.67 $7,717 - $8,992	-24 Reduced 4.77%	479 $0
Q3 2022 Oct 14, 2022	SELL	$296.48 - $337.87 $195,083 - $222,318	-658 Reduced 56.68%	503 $163,000
Q2 2022 Jul 11, 2022	SELL	$278.73 - $327.27 $6.14 Million - $7.21 Million	-22,018 Reduced 94.99%	1,161 $376,000
Q1 2022 May 26, 2022	SELL	$234.69 - $291.66 $1.29 Million - $1.6 Million	-5,495 Reduced 19.16%	23,179 $6.64 Million
Q4 2021 Jan 12, 2022	SELL	$224.85 - $279.04 $299,050 - $371,123	-1,330 Reduced 4.43%	28,674 $7.92 Million
Q3 2021 Oct 18, 2021	BUY	$221.6 - $272.71 $459,376 - $565,327	2,073 Added 7.42%	30,004 $6.93 Million
Q2 2021 Jul 12, 2021	BUY	$180.55 - $233.54 $347,739 - $449,798	1,926 Added 7.41%	27,931 $6.41 Million
Q1 2021 Apr 21, 2021	SELL	$164.32 - $212.72 $9.36 Million - $12.1 Million	-56,975 Reduced 68.66%	26,005 $4.86 Million
Q4 2020 Jan 08, 2021	SELL	$130.46 - $172.63 $130,851 - $173,147	-1,003 Reduced 1.19%	82,980 $12.3 Million
Q3 2020 Oct 06, 2020	BUY	$146.22 - $169.13 $3.73 Million - $4.31 Million	25,503 Added 43.61%	83,983 $12.4 Million
Q2 2020 Jul 10, 2020	SELL	$136.42 - $164.18 $2.19 Million - $2.64 Million	-16,051 Reduced 21.54%	58,480 $9.6 Million
Q1 2020 Apr 07, 2020	SELL	$119.05 - $147.35 $978,233 - $1.21 Million	-8,217 Reduced 9.93%	74,531 $10.3 Million
Q4 2019 Jan 15, 2020	BUY	$106.92 - $132.43 $200,795 - $248,703	1,878 Added 2.32%	82,748 $10.9 Million
Q3 2019 Oct 10, 2019	SELL	$106.79 - $116.16 $879,522 - $956,693	-8,236 Reduced 9.24%	80,870 $9.04 Million
Q2 2019 Jul 16, 2019	BUY	$110.79 - $129.32 $9.58 Million - $11.2 Million	86,488 Added 3303.59%	89,106 $9.87 Million
Q1 2019 Apr 11, 2019	BUY	$111.31 - $131.02 $209,374 - $246,448	1,881 Added 255.22%	2,618 $340,000
Q4 2018 Jan 18, 2019	SELL	$105.9 - $118.64 $19,485 - $21,829	-184 Reduced 19.98%	737 $85,000
Q2 2018 Aug 09, 2018	SELL	$75.7 - $86.88 $908 - $1,042	-12 Reduced 1.29%	921 $79,000
Q1 2018 Apr 11, 2018	SELL	$74.21 - $87.6 $21,669 - $25,579	-292 Reduced 23.84%	933 $72,000
Q4 2017 Feb 07, 2018	BUY	$81.94 - $87.89 $100,376 - $107,665	1,225	1,225 $103,000

Others Institutions Holding LLY

# of Institutions

3,871

Shares Held

751M

Call Options Held

6.34M

Put Options Held

7.97M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $840B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Gradient Investments LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gradient Investments LLC with notifications on news.

Account

Gradient Investments LLC Eli Lilly & CO Transaction History